These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 26839511)

  • 1. A retrospective study of long-term treatment outcomes for reduced vocal intensity in hypokinetic dysarthria.
    Watts CR
    BMC Ear Nose Throat Disord; 2016; 16():2. PubMed ID: 26839511
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Effects of Intensive Voice Treatment in Mandarin Speakers With Parkinson's Disease: Acoustic and Perceptual Findings.
    Hsu SC; Jiao Y; Berisha V; McAuliffe MJ; Lin P; Wu RM; Cheng SJ; Levy ES
    Am J Speech Lang Pathol; 2022 May; 31(3):1354-1367. PubMed ID: 35394803
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PD Check-In: The development and trial of a supported self-management program for people with Parkinson's disease following intensive speech intervention.
    Finnimore A; Theodoros D; Rumbach AF
    Int J Lang Commun Disord; 2022 Jan; 57(1):138-151. PubMed ID: 34767290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of speech cues in French-speaking children with dysarthria.
    Levy ES; Moya-Galé G; Chang YM; Campanelli L; MacLeod AAN; Escorial S; Maillart C
    Int J Lang Commun Disord; 2020 May; 55(3):401-416. PubMed ID: 32077196
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The BioVisualSpeech Serious Game with Voice Exercises for People with Parkinson's Disease with Hypokinetic Dysarthria.
    Viana T; Cavaco S
    Stud Health Technol Inform; 2022 Jun; 290():919-923. PubMed ID: 35673153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lee Silverman Voice Treatment for people with Parkinson's: audit of outcomes in a routine clinic.
    Wight S; Miller N
    Int J Lang Commun Disord; 2015; 50(2):215-25. PubMed ID: 25469736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of increased vocal intensity on interarticulator timing in speakers with Parkinson’s disease: a preliminary analysis.
    Richardson K; Sussman JE; Stathopoulos ET
    J Commun Disord; 2014; 52():44-64. PubMed ID: 25459460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conversational Vocal Intensity in Parkinson's Disease: Treatment and Environmental Comparisons.
    Konnai R; Van Harn M; Silbergleit A
    J Voice; 2023 Sep; 37(5):707-715. PubMed ID: 34134903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurobehavioral Effects of LSVT
    Li Y; Tan M; Fan H; Wang EQ; Chen L; Li J; Chen X; Liu H
    Front Neurosci; 2021; 15():624801. PubMed ID: 33716652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prosodic Improvement in Persons with Parkinson Disease Receiving SPEAK OUT!® Voice Therapy.
    Boutsen F; Park E; Dvorak J; Cid C
    Folia Phoniatr Logop; 2018; 70(2):51-58. PubMed ID: 29996139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acoustic and Perceptual Consequences of Speech Cues for Mandarin Speakers With Parkinson's Disease.
    Hsu SC; McAuliffe MJ; Lin P; Wu RM; Levy ES
    Am J Speech Lang Pathol; 2019 May; 28(2):521-535. PubMed ID: 31136238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased vocal intensity due to the Lombard effect in speakers with Parkinson's disease: simultaneous laryngeal and respiratory strategies.
    Stathopoulos ET; Huber JE; Richardson K; Kamphaus J; DeCicco D; Darling M; Fulcher K; Sussman JE
    J Commun Disord; 2014; 48():1-17. PubMed ID: 24438910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of Lee Silverman Voice Treatment® LOUD on Japanese-Speaking Patients with Parkinson's Disease.
    Nakayama K; Yamamoto T; Oda C; Sato M; Murakami T; Horiguchi S
    Rehabil Res Pract; 2020; 2020():6585264. PubMed ID: 32411475
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical outcomes of PD Check-In, a model for supported self-managed maintenance of speech in Parkinson's disease: A Phase 1 study.
    Finnimore A; Theodoros D; Rumbach AF
    Int J Lang Commun Disord; 2023 Mar; 58(2):241-255. PubMed ID: 36036751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of an extended version of the lee silverman voice treatment on voice and speech in Parkinson's disease.
    Spielman J; Ramig LO; Mahler L; Halpern A; Gavin WJ
    Am J Speech Lang Pathol; 2007 May; 16(2):95-107. PubMed ID: 17456888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypokinetic Dysarthria in Parkinson's Disease: A Narrative Review.
    Atalar MS; Oguz O; Genc G
    Sisli Etfal Hastan Tip Bul; 2023; 57(2):163-170. PubMed ID: 37899809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Speech treatment for Hebrew-speaking adolescents and young adults with developmental dysarthria: A comparison of mSIT and Beatalk.
    Carl M; Levy ES; Icht M
    Int J Lang Commun Disord; 2022 May; 57(3):660-679. PubMed ID: 35363414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Speech and language therapy versus placebo or no intervention for speech problems in Parkinson's disease.
    Herd CP; Tomlinson CL; Deane KH; Brady MC; Smith CH; Sackley CM; Clarke CE
    Cochrane Database Syst Rev; 2012 Aug; 2012(8):CD002812. PubMed ID: 22895930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of an intensive voice treatment on articulatory function and speech intelligibility in children with motor speech disorders: A phase one study.
    Langlois C; Tucker BV; Sawatzky AN; Reed A; Boliek CA
    J Commun Disord; 2020; 86():106003. PubMed ID: 32505858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An Efficacy Study of Voice Quality Using Cepstral Analyses of Phonation in Parkinson's Disease before and after SPEAK-OUT!®.
    Boutsen FR; Park E; Dvorak JD
    Folia Phoniatr Logop; 2023; 75(1):35-42. PubMed ID: 35817007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.